Celldex Therapeutics, Inc.CLDXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | -18.82% |
| Q2 2025 | -4.94% |
| Q1 2025 | -14.08% |
| Q4 2024 | -10.94% |
| Q3 2024 | -18.52% |
| Q2 2024 | 3.57% |
| Q1 2024 | 32.53% |
| Q4 2023 | -2.47% |
| Q3 2023 | -24.62% |
| Q2 2023 | -4.84% |
| Q1 2023 | -10.71% |
| Q4 2022 | 1.75% |
| Q3 2022 | 25.97% |
| Q2 2022 | -57.14% |
| Q1 2022 | -13.95% |
| Q4 2021 | 4.44% |
| Q3 2021 | -32.35% |
| Q2 2021 | 19.05% |
| Q1 2021 | 23.64% |
| Q4 2020 | -52.78% |
| Q3 2020 | 28.00% |
| Q2 2020 | 31.51% |
| Q1 2020 | -14.06% |
| Q4 2019 | 14.67% |
| Q3 2019 | 10.71% |
| Q2 2019 | 40.00% |
| Q1 2019 | -72.84% |
| Q4 2018 | -22.73% |
| Q3 2018 | 60.48% |
| Q2 2018 | 86.76% |
| Q1 2018 | -2902.38% |
| Q4 2017 | 86.23% |
| Q3 2017 | 10.82% |
| Q2 2017 | 18.38% |
| Q1 2017 | 6.68% |
| Q4 2016 | -1.81% |
| Q3 2016 | 9.07% |
| Q2 2016 | 7.97% |
| Q1 2016 | -6.04% |
| Q4 2015 | -2.05% |